|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:FUS-FEV (FusionGDB2 ID:31802) |
Fusion Gene Summary for FUS-FEV |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: FUS-FEV | Fusion gene ID: 31802 | Hgene | Tgene | Gene symbol | FUS | FEV | Gene ID | 2521 | 54738 |
| Gene name | FUS RNA binding protein | FEV transcription factor, ETS family member | |
| Synonyms | ALS6|ETM4|FUS1|HNRNPP2|POMP75|TLS | HSRNAFEV|PET-1 | |
| Cytomap | 16p11.2 | 2q35 | |
| Type of gene | protein-coding | protein-coding | |
| Description | RNA-binding protein FUS75 kDa DNA-pairing proteinfus-like proteinfused in sarcomafusion gene in myxoid liposarcomaheterogeneous nuclear ribonucleoprotein P2oncogene FUSoncogene TLStranslocated in liposarcoma protein | protein FEVFEV (ETS oncogene family)FEV, ETS transcription factorPC12 ETS domain-containing transcription factor 1fifth Ewing variant protein | |
| Modification date | 20200329 | 20200313 | |
| UniProtAcc | P35637 | Q99581 | |
| Ensembl transtripts involved in fusion gene | ENST00000474990, ENST00000254108, ENST00000380244, ENST00000568685, | ENST00000295727, | |
| Fusion gene scores | * DoF score | 37 X 37 X 16=21904 | 3 X 2 X 2=12 |
| # samples | 44 | 2 | |
| ** MAII score | log2(44/21904*10)=-5.63754701773324 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(2/12*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: FUS [Title/Abstract] AND FEV [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | |||
| Anticipated loss of major functional domain due to fusion event. | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | FUS | GO:0006355 | regulation of transcription, DNA-templated | 26124092 |
| Hgene | FUS | GO:0006357 | regulation of transcription by RNA polymerase II | 25453086 |
| Hgene | FUS | GO:0008380 | RNA splicing | 26124092 |
| Hgene | FUS | GO:0043484 | regulation of RNA splicing | 25453086|27731383 |
| Hgene | FUS | GO:0048255 | mRNA stabilization | 27378374 |
| Hgene | FUS | GO:0051260 | protein homooligomerization | 25453086 |
| Hgene | FUS | GO:1905168 | positive regulation of double-strand break repair via homologous recombination | 10567410 |
| Fusion gene breakpoints across FUS (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene breakpoints across FEV (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerKB3 | . | . | FUS | chr16 | 31201115 | + | FEV | chr2 | 219849027 | - |
Top |
Fusion Gene ORF analysis for FUS-FEV |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 3UTR-3CDS | ENST00000474990 | ENST00000295727 | FUS | chr16 | 31201115 | + | FEV | chr2 | 219849027 | - |
| In-frame | ENST00000254108 | ENST00000295727 | FUS | chr16 | 31201115 | + | FEV | chr2 | 219849027 | - |
| In-frame | ENST00000380244 | ENST00000295727 | FUS | chr16 | 31201115 | + | FEV | chr2 | 219849027 | - |
| In-frame | ENST00000568685 | ENST00000295727 | FUS | chr16 | 31201115 | + | FEV | chr2 | 219849027 | - |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000254108 | FUS | chr16 | 31201115 | + | ENST00000295727 | FEV | chr2 | 219849027 | - | 2416 | 1171 | 27 | 1835 | 602 |
| ENST00000380244 | FUS | chr16 | 31201115 | + | ENST00000295727 | FEV | chr2 | 219849027 | - | 2384 | 1139 | 52 | 1803 | 583 |
| ENST00000568685 | FUS | chr16 | 31201115 | + | ENST00000295727 | FEV | chr2 | 219849027 | - | 2378 | 1133 | 40 | 1797 | 585 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for FUS-FEV |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for FUS-FEV |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr16:/chr2:) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| FUS | FEV |
| FUNCTION: DNA/RNA-binding protein that plays a role in various cellular processes such as transcription regulation, RNA splicing, RNA transport, DNA repair and damage response (PubMed:27731383). Binds to nascent pre-mRNAs and acts as a molecular mediator between RNA polymerase II and U1 small nuclear ribonucleoprotein thereby coupling transcription and splicing (PubMed:26124092). Binds also its own pre-mRNA and autoregulates its expression; this autoregulation mechanism is mediated by non-sense-mediated decay (PubMed:24204307). Plays a role in DNA repair mechanisms by promoting D-loop formation and homologous recombination during DNA double-strand break repair (PubMed:10567410). In neuronal cells, plays crucial roles in dendritic spine formation and stability, RNA transport, mRNA stability and synaptic homeostasis (By similarity). {ECO:0000250|UniProtKB:P56959, ECO:0000269|PubMed:10567410, ECO:0000269|PubMed:24204307, ECO:0000269|PubMed:26124092, ECO:0000269|PubMed:27731383}. | FUNCTION: Functions as a transcriptional regulator. According to PubMed:12761502, it functions as a transcriptional repressor. Functions in the differentiation and the maintenance of the central serotonergic neurons. May play a role in cell growth. {ECO:0000269|PubMed:12761502}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for FUS-FEV |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >31802_31802_1_FUS-FEV_FUS_chr16_31201115_ENST00000254108_FEV_chr2_219849027_ENST00000295727_length(transcript)=2416nt_BP=1171nt ACTTAAGCTTCGACGCAGGAGGCGGGGCTGCTCAGTCCTCCAGGCGTCGGTACTCAGCGGTGTTGGAACTTCGTTGCTTGCTTGCCTGTG CGCGCGTGCGCGGACATGGCCTCAAACGATTATACCCAACAAGCAACCCAAAGCTATGGGGCCTACCCCACCCAGCCCGGGCAGGGCTAT TCCCAGCAGAGCAGTCAGCCCTACGGACAGCAGAGTTACAGTGGTTATAGCCAGTCCACGGACACTTCAGGCTATGGCCAGAGCAGCTAT TCTTCTTATGGCCAGAGCCAGAACACAGGCTATGGAACTCAGTCAACTCCCCAGGGATATGGCTCGACTGGCGGCTATGGCAGTAGCCAG AGCTCCCAATCGTCTTACGGGCAGCAGTCCTCCTACCCTGGCTATGGCCAGCAGCCAGCTCCCAGCAGCACCTCGGGAAGTTACGGTAGC AGTTCTCAGAGCAGCAGCTATGGGCAGCCCCAGAGTGGGAGCTACAGCCAGCAGCCTAGCTATGGTGGACAGCAGCAAAGCTATGGACAG CAGCAAAGCTATAATCCCCCTCAGGGCTATGGACAGCAGAACCAGTACAACAGCAGCAGTGGTGGTGGAGGTGGAGGTGGAGGTGGAGGT AACTATGGCCAAGATCAATCCTCCATGAGTAGTGGTGGTGGCAGTGGTGGCGGTTATGGCAATCAAGACCAGAGTGGTGGAGGTGGCAGC GGTGGCTATGGACAGCAGGACCGTGGAGGCCGCGGCAGGGGTGGCAGTGGTGGCGGCGGCGGCGGCGGCGGTGGTGGTTACAACCGCAGC AGTGGTGGCTATGAACCCAGAGGTCGTGGAGGTGGCCGTGGAGGCAGAGGTGGCATGGGCGGAAGTGACCGTGGTGGCTTCAATAAATTT GGTGGCCCTCGGGACCAAGGATCACGTCATGACTCCGAACAGGATAATTCAGACAACAACACCATCTTTGTGCAAGGCCTGGGTGAGAAT GTTACAATTGAGTCTGTGGCTGATTACTTCAAGCAGATTGGTATTATTAAGACAAACAAGAAAACGGGACAGCCCATGATTAATTTGTAC ACAGACAGGGAAACTGGCAAGCTGAAGGGAGAGGCAACGGTCTCTTTTGATGACCCACCTTCAGCTAAAGCAGCTATTGACTGGTTTGAT GATCCCGTCGGAGACGGTCTCTTCAAGGACGGGAAGAACCCGAGCTGGGGGCCGCTGAGCCCCGCGGTTCAGAAAGGCAGCGGACAGATC CAGCTGTGGCAGTTTCTGCTGGAGCTGCTGGCTGACCGCGCGAACGCCGGCTGCATCGCGTGGGAGGGCGGTCACGGCGAGTTCAAGCTC ACGGACCCGGACGAGGTGGCGCGGCGGTGGGGCGAGCGCAAGAGCAAGCCCAACATGAACTACGACAAGCTGAGCCGCGCCCTGCGCTAC TACTACGACAAGAACATCATGAGCAAGGTGCATGGCAAGCGCTACGCCTACCGCTTCGACTTCCAGGGCCTGGCGCAGGCCTGCCAGCCG CCGCCCGCGCACGCTCATGCCGCCGCCGCAGCTGCTGCCGCCGCCGCGGCCGCCCAGGACGGCGCGCTCTACAAGCTGCCCGCCGGCCTC GCCCCGCTGCCCTTCCCCGGCCTCTCCAAACTCAACCTCATGGCCGCCTCGGCCGGGGTCGCGCCCGCCGGCTTCTCCTACTGGCCGGGC CCGGGCCCCGCCGCCACCGCTGCCGCCGCCACCGCCGCGCTCTACCCCAGTCCCAGCTTGCAGCCCCCGCCCGGGCCCTTCGGGGCCGTG GCCGCAGCCTCGCACTTGGGGGGCCATTACCACTAGACGGGGCGGTCGGGTGCCTGCGGCCTCGCCCGCACGCCTAGAGTCTCGCCCGAT CCCATCGGCATCCCGGGGAGGGCCCGGGAGCCTCCGTCAACCGTCCTCTAATCCAGAGTTTACTCCACCTGCCGCACTTAGCAGGGGGAC GGGACCGAAGCTCCCTCAATCCTTGTCTGGTACTAGATTTGCTCCTGTCCCACCCCGCAGTCCCCTGAGGAGGGCGATGTGCGCCCTCTT TCACTTTTTTTCTTCTAGGTCTCCAGGTCCCGGAGGGGATTTGTGGACCTCTCTTGTCTCCCCACCACTCCAGTGCATTTCCGCCTGGCT CCTAGAAGCCCCATTCAATATCACTACTCTTTAACGAGTGCCAAATCTTTTCCCACTTTTGCTCTTCCCCAAGGAACTGCTCCCACCTCA GCACGTGGAGGCCTCTCACGGTCCTCCTTCCTGGGACCTGAGCAGGTTTGGTGAAAGCCACCGTCCTCCGTGACACACGGCCCCCTTCCT >31802_31802_1_FUS-FEV_FUS_chr16_31201115_ENST00000254108_FEV_chr2_219849027_ENST00000295727_length(amino acids)=602AA_BP=239 MLSPPGVGTQRCWNFVACLPVRACADMASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQSQNT GYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSSSYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQG YGQQNQYNSSSGGGGGGGGGGNYGQDQSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSGGYEPRGR GGGRGGRGGMGGSDRGGFNKFGGPRDQGSRHDSEQDNSDNNTIFVQGLGENVTIESVADYFKQIGIIKTNKKTGQPMINLYTDRETGKLK GEATVSFDDPPSAKAAIDWFDDPVGDGLFKDGKNPSWGPLSPAVQKGSGQIQLWQFLLELLADRANAGCIAWEGGHGEFKLTDPDEVARR WGERKSKPNMNYDKLSRALRYYYDKNIMSKVHGKRYAYRFDFQGLAQACQPPPAHAHAAAAAAAAAAAAQDGALYKLPAGLAPLPFPGLS -------------------------------------------------------------- >31802_31802_2_FUS-FEV_FUS_chr16_31201115_ENST00000380244_FEV_chr2_219849027_ENST00000295727_length(transcript)=2384nt_BP=1139nt GCTCAGTCCTCCAGGCGTCGGTACTCAGCGGTGTTGGAACTTCGTTGCTTGCTTGCCTGTGCGCGCGTGCGCGGACATGGCCTCAAACGA TTATACCCAACAAGCAACCCAAAGCTATGGGGCCTACCCCACCCAGCCCGGGCAGGGCTATTCCCAGCAGAGCAGTCAGCCCTACGGACA GCAGAGTTACAGTGGTTATAGCCAGTCCACGGACACTTCAGGCTATGGCCAGAGCAGCTATTCTTCTTATGGCCAGAGCCAGAACAGCTA TGGAACTCAGTCAACTCCCCAGGGATATGGCTCGACTGGCGGCTATGGCAGTAGCCAGAGCTCCCAATCGTCTTACGGGCAGCAGTCCTC CTACCCTGGCTATGGCCAGCAGCCAGCTCCCAGCAGCACCTCGGGAAGTTACGGTAGCAGTTCTCAGAGCAGCAGCTATGGGCAGCCCCA GAGTGGGAGCTACAGCCAGCAGCCTAGCTATGGTGGACAGCAGCAAAGCTATGGACAGCAGCAAAGCTATAATCCCCCTCAGGGCTATGG ACAGCAGAACCAGTACAACAGCAGCAGTGGTGGTGGAGGTGGAGGTGGAGGTGGAGGTAACTATGGCCAAGATCAATCCTCCATGAGTAG TGGTGGTGGCAGTGGTGGCGGTTATGGCAATCAAGACCAGAGTGGTGGAGGTGGCAGCGGTGGCTATGGACAGCAGGACCGTGGAGGCCG CGGCAGGGGTGGCAGTGGTGGCGGCGGCGGCGGCGGCGGTGGTGGTTACAACCGCAGCAGTGGTGGCTATGAACCCAGAGGTCGTGGAGG TGGCCGTGGAGGCAGAGGTGGCATGGGCGGAAGTGACCGTGGTGGCTTCAATAAATTTGGTGGCCCTCGGGACCAAGGATCACGTCATGA CTCCGAACAGGATAATTCAGACAACAACACCATCTTTGTGCAAGGCCTGGGTGAGAATGTTACAATTGAGTCTGTGGCTGATTACTTCAA GCAGATTGGTATTATTAAGACAAACAAGAAAACGGGACAGCCCATGATTAATTTGTACACAGACAGGGAAACTGGCAAGCTGAAGGGAGA GGCAACGGTCTCTTTTGATGACCCACCTTCAGCTAAAGCAGCTATTGACTGGTTTGATGATCCCGTCGGAGACGGTCTCTTCAAGGACGG GAAGAACCCGAGCTGGGGGCCGCTGAGCCCCGCGGTTCAGAAAGGCAGCGGACAGATCCAGCTGTGGCAGTTTCTGCTGGAGCTGCTGGC TGACCGCGCGAACGCCGGCTGCATCGCGTGGGAGGGCGGTCACGGCGAGTTCAAGCTCACGGACCCGGACGAGGTGGCGCGGCGGTGGGG CGAGCGCAAGAGCAAGCCCAACATGAACTACGACAAGCTGAGCCGCGCCCTGCGCTACTACTACGACAAGAACATCATGAGCAAGGTGCA TGGCAAGCGCTACGCCTACCGCTTCGACTTCCAGGGCCTGGCGCAGGCCTGCCAGCCGCCGCCCGCGCACGCTCATGCCGCCGCCGCAGC TGCTGCCGCCGCCGCGGCCGCCCAGGACGGCGCGCTCTACAAGCTGCCCGCCGGCCTCGCCCCGCTGCCCTTCCCCGGCCTCTCCAAACT CAACCTCATGGCCGCCTCGGCCGGGGTCGCGCCCGCCGGCTTCTCCTACTGGCCGGGCCCGGGCCCCGCCGCCACCGCTGCCGCCGCCAC CGCCGCGCTCTACCCCAGTCCCAGCTTGCAGCCCCCGCCCGGGCCCTTCGGGGCCGTGGCCGCAGCCTCGCACTTGGGGGGCCATTACCA CTAGACGGGGCGGTCGGGTGCCTGCGGCCTCGCCCGCACGCCTAGAGTCTCGCCCGATCCCATCGGCATCCCGGGGAGGGCCCGGGAGCC TCCGTCAACCGTCCTCTAATCCAGAGTTTACTCCACCTGCCGCACTTAGCAGGGGGACGGGACCGAAGCTCCCTCAATCCTTGTCTGGTA CTAGATTTGCTCCTGTCCCACCCCGCAGTCCCCTGAGGAGGGCGATGTGCGCCCTCTTTCACTTTTTTTCTTCTAGGTCTCCAGGTCCCG GAGGGGATTTGTGGACCTCTCTTGTCTCCCCACCACTCCAGTGCATTTCCGCCTGGCTCCTAGAAGCCCCATTCAATATCACTACTCTTT AACGAGTGCCAAATCTTTTCCCACTTTTGCTCTTCCCCAAGGAACTGCTCCCACCTCAGCACGTGGAGGCCTCTCACGGTCCTCCTTCCT GGGACCTGAGCAGGTTTGGTGAAAGCCACCGTCCTCCGTGACACACGGCCCCCTTCCTCCTGTCCCCACACTCCCAGGAGAAACTCCCGG >31802_31802_2_FUS-FEV_FUS_chr16_31201115_ENST00000380244_FEV_chr2_219849027_ENST00000295727_length(amino acids)=583AA_BP=220 MPVRACADMASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQSQNSYGTQSTPQGYGSTGGYGS SQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSSSYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGG GGNYGQDQSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSGGYEPRGRGGGRGGRGGMGGSDRGGFN KFGGPRDQGSRHDSEQDNSDNNTIFVQGLGENVTIESVADYFKQIGIIKTNKKTGQPMINLYTDRETGKLKGEATVSFDDPPSAKAAIDW FDDPVGDGLFKDGKNPSWGPLSPAVQKGSGQIQLWQFLLELLADRANAGCIAWEGGHGEFKLTDPDEVARRWGERKSKPNMNYDKLSRAL RYYYDKNIMSKVHGKRYAYRFDFQGLAQACQPPPAHAHAAAAAAAAAAAAQDGALYKLPAGLAPLPFPGLSKLNLMAASAGVAPAGFSYW -------------------------------------------------------------- >31802_31802_3_FUS-FEV_FUS_chr16_31201115_ENST00000568685_FEV_chr2_219849027_ENST00000295727_length(transcript)=2378nt_BP=1133nt AGGCGTCGGTACTCAGCGGTGTTGGAACTTCGTTGCTTGCTTGCCTGTGCGCGCGTGCGCGGACATGGCCTCAAACGATTATACCCAACA AGCAACCCAAAGCTATGGGGCCTACCCCACCCAGCCCGGGCAGGGCTATTCCCAGCAGAGCAGTCAGCCCTACGGACAGCAGAGTTACAG TGGTTATAGCCAGTCCACGGACACTTCAGGCTATGGCCAGAGCAGCTATTCTTCTTATGGCCAGAGCCAGAACACAGGCTATGGAACTCA GTCAACTCCCCAGGGATATGGCTCGACTGGCGGCTATGGCAGTAGCCAGAGCTCCCAATCGTCTTACGGGCAGCAGTCCTCCTACCCTGG CTATGGCCAGCAGCCAGCTCCCAGCAGCACCTCGGGAAGTTACGGTAGCAGTTCTCAGAGCAGCAGCTATGGGCAGCCCCAGAGTGGGAG CTACAGCCAGCAGCCTAGCTATGGTGGACAGCAGCAAAGCTATGGACAGCAGCAAAGCTATAATCCCCCTCAGGGCTATGGACAGCAGAA CCAGTACAACAGCAGCAGTGGTGGTGGAGGTGGAGGTGGAGGTGGAGGTAACTATGGCCAAGATCAATCCTCCATGAGTAGTGGTGGTGG CAGTGGTGGCGGTTATGGCAATCAAGACCAGAGTGGTGGAGGTGGCAGCGGTGGCTATGGACAGCAGGACCGTGGAGGCCGCGGCAGGGG TGGCAGTGGTGGCGGCGGCGGCGGCGGCGGTGGTGGTTACAACCGCAGCAGTGGTGGCTATGAACCCAGAGGTCGTGGAGGTGGCCGTGG AGGCAGAGGTGGCATGGGCGGAAGTGACCGTGGTGGCTTCAATAAATTTGGTGGCCCTCGGGACCAAGGATCACGTCATGACTCCGCAGA ACAGGATAATTCAGACAACAACACCATCTTTGTGCAAGGCCTGGGTGAGAATGTTACAATTGAGTCTGTGGCTGATTACTTCAAGCAGAT TGGTATTATTAAGACAAACAAGAAAACGGGACAGCCCATGATTAATTTGTACACAGACAGGGAAACTGGCAAGCTGAAGGGAGAGGCAAC GGTCTCTTTTGATGACCCACCTTCAGCTAAAGCAGCTATTGACTGGTTTGATGATCCCGTCGGAGACGGTCTCTTCAAGGACGGGAAGAA CCCGAGCTGGGGGCCGCTGAGCCCCGCGGTTCAGAAAGGCAGCGGACAGATCCAGCTGTGGCAGTTTCTGCTGGAGCTGCTGGCTGACCG CGCGAACGCCGGCTGCATCGCGTGGGAGGGCGGTCACGGCGAGTTCAAGCTCACGGACCCGGACGAGGTGGCGCGGCGGTGGGGCGAGCG CAAGAGCAAGCCCAACATGAACTACGACAAGCTGAGCCGCGCCCTGCGCTACTACTACGACAAGAACATCATGAGCAAGGTGCATGGCAA GCGCTACGCCTACCGCTTCGACTTCCAGGGCCTGGCGCAGGCCTGCCAGCCGCCGCCCGCGCACGCTCATGCCGCCGCCGCAGCTGCTGC CGCCGCCGCGGCCGCCCAGGACGGCGCGCTCTACAAGCTGCCCGCCGGCCTCGCCCCGCTGCCCTTCCCCGGCCTCTCCAAACTCAACCT CATGGCCGCCTCGGCCGGGGTCGCGCCCGCCGGCTTCTCCTACTGGCCGGGCCCGGGCCCCGCCGCCACCGCTGCCGCCGCCACCGCCGC GCTCTACCCCAGTCCCAGCTTGCAGCCCCCGCCCGGGCCCTTCGGGGCCGTGGCCGCAGCCTCGCACTTGGGGGGCCATTACCACTAGAC GGGGCGGTCGGGTGCCTGCGGCCTCGCCCGCACGCCTAGAGTCTCGCCCGATCCCATCGGCATCCCGGGGAGGGCCCGGGAGCCTCCGTC AACCGTCCTCTAATCCAGAGTTTACTCCACCTGCCGCACTTAGCAGGGGGACGGGACCGAAGCTCCCTCAATCCTTGTCTGGTACTAGAT TTGCTCCTGTCCCACCCCGCAGTCCCCTGAGGAGGGCGATGTGCGCCCTCTTTCACTTTTTTTCTTCTAGGTCTCCAGGTCCCGGAGGGG ATTTGTGGACCTCTCTTGTCTCCCCACCACTCCAGTGCATTTCCGCCTGGCTCCTAGAAGCCCCATTCAATATCACTACTCTTTAACGAG TGCCAAATCTTTTCCCACTTTTGCTCTTCCCCAAGGAACTGCTCCCACCTCAGCACGTGGAGGCCTCTCACGGTCCTCCTTCCTGGGACC TGAGCAGGTTTGGTGAAAGCCACCGTCCTCCGTGACACACGGCCCCCTTCCTCCTGTCCCCACACTCCCAGGAGAAACTCCCGGTGTGTT >31802_31802_3_FUS-FEV_FUS_chr16_31201115_ENST00000568685_FEV_chr2_219849027_ENST00000295727_length(amino acids)=585AA_BP=221 MPVRACADMASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQSQNTGYGTQSTPQGYGSTGGYG SSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSSSYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGG GGGNYGQDQSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRGGRGRGGSGGGGGGGGGGYNRSSGGYEPRGRGGGRGGRGGMGGSDRGGF NKFGGPRDQGSRHDSAEQDNSDNNTIFVQGLGENVTIESVADYFKQIGIIKTNKKTGQPMINLYTDRETGKLKGEATVSFDDPPSAKAAI DWFDDPVGDGLFKDGKNPSWGPLSPAVQKGSGQIQLWQFLLELLADRANAGCIAWEGGHGEFKLTDPDEVARRWGERKSKPNMNYDKLSR ALRYYYDKNIMSKVHGKRYAYRFDFQGLAQACQPPPAHAHAAAAAAAAAAAAQDGALYKLPAGLAPLPFPGLSKLNLMAASAGVAPAGFS -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for FUS-FEV |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for FUS-FEV |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for FUS-FEV |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies